These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 12054572)

  • 1. Identification of the regulatory region required for ubiquitination of the cyclin kinase inhibitor, p21.
    Fukuchi K; Hagiwara T; Nakamura K; Ichimura S; Tatsumi K; Gomi K
    Biochem Biophys Res Commun; 2002 Apr; 293(1):120-5. PubMed ID: 12054572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.
    Coulombe P; Rodier G; Bonneil E; Thibault P; Meloche S
    Mol Cell Biol; 2004 Jul; 24(14):6140-50. PubMed ID: 15226418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The central region of Gadd45 is required for its interaction with p21/WAF1.
    Zhao H; Jin S; Antinore MJ; Lung FD; Fan F; Blanck P; Roller P; Fornace AJ; Zhan Q
    Exp Cell Res; 2000 Jul; 258(1):92-100. PubMed ID: 10912791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun NH2-terminal kinase decreases ubiquitination and promotes stabilization of p21(WAF1/CIP1) in K562 cell.
    Fan Y; Chen H; Qiao B; Liu Z; Luo L; Wu Y; Yin Z
    Biochem Biophys Res Commun; 2007 Mar; 355(1):263-8. PubMed ID: 17292858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation.
    Soria G; Podhajcer O; Prives C; Gottifredi V
    Oncogene; 2006 May; 25(20):2829-38. PubMed ID: 16407842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of DNA binding and in vitro transcriptional activities dependent on the C terminus of P53 proteins.
    Kaku S; Albor A; Kulesz-Martin M
    Biochem Biophys Res Commun; 2001 Jan; 280(1):204-11. PubMed ID: 11162500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the region required for the antiapoptotic function of the cyclin kinase inhibitor, p21.
    Nakamura K; Arai D; Fukuchi K
    Arch Biochem Biophys; 2004 Nov; 431(1):47-54. PubMed ID: 15464725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins.
    Mollah S; Wertz IE; Phung Q; Arnott D; Dixit VM; Lill JR
    Rapid Commun Mass Spectrom; 2007; 21(20):3357-64. PubMed ID: 17883243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome.
    Berse M; Bounpheng M; Huang X; Christy B; Pollmann C; Dubiel W
    J Mol Biol; 2004 Oct; 343(2):361-70. PubMed ID: 15451666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal 15-48 region of cyclin kinase inhibitor p21 is a determinant of basal expression.
    Nomura N; Yamaguchi F; Fukuchi K
    Cancer Genomics Proteomics; 2007; 4(2):71-80. PubMed ID: 17804869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107.
    Chibazakura T; McGrew SG; Cooper JA; Yoshikawa H; Roberts JM
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4465-70. PubMed ID: 15070741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase.
    Amir RE; Haecker H; Karin M; Ciechanover A
    Oncogene; 2004 Apr; 23(14):2540-7. PubMed ID: 14676825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
    Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
    Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paired-like homeodomain protein ESXR1 possesses a cleavable C-terminal region that inhibits cyclin degradation.
    Ozawa H; Ashizawa S; Naito M; Yanagihara M; Ohnishi N; Maeda T; Matsuda Y; Jo Y; Higashi H; Kakita A; Hatakeyama M
    Oncogene; 2004 Aug; 23(39):6590-602. PubMed ID: 15235584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the regulatory autophosphorylation site of autophosphorylation-dependent protein kinase (auto-kinase). Evidence that auto-kinase belongs to a member of the p21-activated kinase family.
    Yu JS; Chen WJ; Ni MH; Chan WH; Yang SD
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):121-31. PubMed ID: 9693111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates.
    King RW; Glotzer M; Kirschner MW
    Mol Biol Cell; 1996 Sep; 7(9):1343-57. PubMed ID: 8885231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation.
    Bloom J; Amador V; Bartolini F; DeMartino G; Pagano M
    Cell; 2003 Oct; 115(1):71-82. PubMed ID: 14532004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of cyclin Y by CDK14 induces its ubiquitination and degradation.
    Li S; Song W; Jiang M; Zeng L; Zhu X; Chen J
    FEBS Lett; 2014 May; 588(11):1989-96. PubMed ID: 24794231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells.
    Fukuchi K; Tomoyasu S; Nakamaki T; Tsuruoka N; Gomi K
    Biochim Biophys Acta; 1998 Sep; 1404(3):405-11. PubMed ID: 9739169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brap2 functions as a cytoplasmic retention protein for p21 during monocyte differentiation.
    Asada M; Ohmi K; Delia D; Enosawa S; Suzuki S; Yuo A; Suzuki H; Mizutani S
    Mol Cell Biol; 2004 Sep; 24(18):8236-43. PubMed ID: 15340083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.